Literature DB >> 18976144

Antegrade endopyelotomy versus laparoscopic pyeloplasty for primary ureteropelvic junction obstruction.

Tomasz Szydełko1, Roman Kopeć, Jarosław Kasprzak, Wojciech Apoznański, Anna Kołodziej, Romuald Zdrojowy, Jerzy Lorenz.   

Abstract

OBJECTIVES: A retrospective study was performed to compare the results of laparoscopic pyeloplasty and antegrade endopyelotomy and complications observed after the two procedures.
MATERIALS AND METHODS: Seventy-five endopyelotomies and 90 laparoscopic pyeloplasties in patients with primary ureteropelvic junction obstruction (UPJO) were performed. The diagnosis of UPJO was based on a complete medical history, ultrasonography, urography (IVU), and/or diuretic renography. In 52 cases, a Whitaker test was performed before endopyelotomy. The mean follow-up was 31 months in the endopyelotomy group and 28.5 months in the laparoscopy group. Complete success was defined as absence of any clinical symptoms combined with significant reduction of hydronephrosis on diuretic IVU and ultrasonography, and no sign of obstruction on diuretic IVU, diuretic renography, or Whitaker test.
RESULTS: Complete success was observed in 55.4% of patients after endopyelotomy and in 95.3% of patients after laparoscopic pyeloplasty. In patients with primary UPJO, laparoscopic procedures yield better therapeutic results than endopyelotomy, irrespective of the degree of hydronephrosis. The number of complications after the two procedures was comparable with the exception of intraoperative bleeding, which was more frequent in the case of endopyelotomy.
CONCLUSIONS: Laparoscopic pyeloplasty should be the procedure of choice in the treatment of primary UPJO.

Entities:  

Mesh:

Year:  2009        PMID: 18976144     DOI: 10.1089/lap.2008.0104

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  8 in total

Review 1.  Endopyelotomy in the age of laparoscopic and robotic-assisted pyeloplasty.

Authors:  Daniel Yong; David M Albala
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

2.  Laparoscopic pyeloplasty: the standard of care for ureteropelvic junction obstruction.

Authors:  Anil Kapoor; Christopher B Allard
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

3.  Retroperitoneoscopic pyeloplasty for the management of pelvic-ureteric junction obstruction in horseshoe kidney: our initial experience.

Authors:  Rahul Janak Sinha; Ankur Jhanwar; Vishwajeet Singh; Gaurav Prakash
Journal:  BMJ Case Rep       Date:  2016-07-08

Review 4.  Minimally Invasive Techniques for the Management of Adult UPJ Obstruction.

Authors:  Marshall C Strother; Phillip Mucksavage
Journal:  Curr Urol Rep       Date:  2016-05       Impact factor: 3.092

5.  Role of laparoscopy in ureteropelvic junction obstruction with concomitant pathology: a case series study.

Authors:  Omar Fahmy; Abdel-Rahman El-Fayoumi; Georgios Gakis; Bastian Amend; Mohd Ghani Khairul-Asri; Arnulf Stenzl; Christian Schwentner
Journal:  Cent European J Urol       Date:  2015-12-21

Review 6.  Management of ureteropelvic junction obstruction in adults.

Authors:  Fahd Khan; Kamran Ahmed; Nikiesha Lee; Ben Challacombe; Mohammed S Khan; Prokar Dasgupta
Journal:  Nat Rev Urol       Date:  2014-10-07       Impact factor: 14.432

7.  Simultaneous laparoscopic management of ureteropelvic junction obstruction and renal lithiasis: the combined experience of two academic centers and review of the literature.

Authors:  Konstantinos G Stravodimos; Stilianos Giannakopoulos; Stavros I Tyritzis; Aristeides Alevizopoulos; Stefanos Papadoukakis; Stavros Touloupidis; Constantinos A Constantinides
Journal:  Res Rep Urol       Date:  2014-05-20

8.  Comparison Between Diuretic Urography (IVP) and Diuretic Renography for Diagnosis of Ureteropelvic Junction Obstruction in Children.

Authors:  Mohammad Esmaeili; Marjan Esmaeili; Fatemeh Ghane; Ali Alamdaran
Journal:  Iran J Pediatr       Date:  2016-01-30       Impact factor: 0.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.